Coronary Reperfusion. & Secondary Prevention. Oberlech, Austria April 14 19, 2007 H. DARIUS K. HUBER A. M. ROSS P R O R A A ORGANIZERS:

Size: px

Start display at page:

Download "Coronary Reperfusion. & Secondary Prevention. Oberlech, Austria April 14 19, 2007 H. DARIUS K. HUBER A. M. ROSS P R O R A A ORGANIZERS:"

Michael McCormick
6 years ago
Views:

1 Coronary Reperfusion & Secondary Prevention ORGANIZERS: H. DARIUS K. HUBER A. M. ROSS Oberlech, Austria April 14 19, 2007 TOPICS: Acute Coronary Syndromes Antithrombins Antiplatelet Therapy ASD+PFO Closure Case Reports: How To Do Case Reports: How Not To Do Controversies High Risk Groups in ACS Interventional Cardiology Meet-the-Experts New Devices for PCI Primary PCI Secondary Prevention Update STEMI: Reperfusion Strategies Stent Thrombosis Syncope Thrombolysis F I P R O N G R A A L M

2 GENERAL INFORMATION Local Organisation Kurt Huber, MD, FESC, FACC Director, 3 rd Department of Medicine (Cardiology & Emergency Medicine), Wilhelminenhospital Montleartstrasse 37, A-1160 Vienna, Austria Tel.: (+43/1) Fax: (+43/1) kurt.huber@wienkav.at Medical Exhibition and Advertising Medizinische Ausstellungs- und Werbegesellschaft Contact: Ms. Sonja Chmella Freyung 6, A-1014 Vienna, Austria Tel.: (+43/1) Fax: (+43/1) maw@media.co.at, Venue Burghotel, Oberlech A-6764 Lech am Arlberg, Austria Contact: Ms. Monika Seelhofer Tel.: (+43/5583) Fax: (+43/5583) monika.seelhofer@burghotel.at Congress Fee: 600, The meeting is organized under the auspices of the Working Group on Thrombosis of the European Society of Cardiology Internet-Information: Printed in Austria by: ROBIDRUCK, A-1200 Vienna, Engerthstrasse 128 (+43/1) Fax: (+43/1) office@robidruck.co.at 2

3 SCIENTIFIC PROGRAM Saturday, April 14, 2007 Arrival Day Welcome Reception Burghotel SCIENTIFIC PROGRAM Sunday, April 15, Main Lecture I Chair: A. Ross (USA) Coronary Revascularization in High Risk Groups (S. King III, USA) Meet the Experts I Metabolic States (T. Wascher, A, K. Huber, A) Coffee Break Poster Discussion I (Stent Thrombosis) Moderator: S. Kristensen (DK) Lunch, Afternoon Break Symposium 1 Stenting of the Coronaries Moderators: O. Pachinger (A), H. Schühlen (D) Do We Have to Re-Evaluate the Indications for Drug Eluting Stents? (S. King III, USA) Mechanisms of Stent Thrombosis (S. Kristensen, DK) The Open Artery -Hypothesis is Closed (F. W. A. Verheugt, NL) Bleeding and Transfusion Determine Outcome After PCI (G. Steg, F) Radial Access PCI Is Associated with Reduced Transfusion and 1-Year Mortality: Insights from the British Columbia Cardiac Registry (P. Klinke, CDN) Coffee Break Symposium 2 Case Reports: Coronary Interventions: How Not To Do Moderators: P. Probst (A), U. Sigwart (CH) How to Avoid Complications (U. Sigwart, CH) Case Presenters: H. Darius (D), G. Gaul (A), D. Gulba (D), H. Schühlen (D), R. Zimmermann (CDN) 3

4 SCIENTIFIC PROGRAM Monday, April 16, Main Lecture II Chair: H. Darius (D) Low- and Non-Responders to Antiplatelet Agents: Definition, Detection, Treatment (K. Schrör, D) Meet the Experts II Enoxaparin in ACS (G. Montalescot, F, K. Huber, A) Coffee Break Poster Discussion II (Antithrombins in ACS and Coronary Intervention) Moderator: R. De Caterina (I) Lunch, Afternoon Break Symposium 3 Clinical Use of New Antithrombotic Strategies Moderators: R. Welsh (CDN), S. Kristensen (DK) Bivalirudin in UA and NSTEMI (R. De Caterina, I) Fondaparinux in NSTEMI and STEMI (H.-J. Rupprecht, D) Clopidogrel in Acute STEMI: A New Indication (U. Zeymer, D) Prasugrel - Superior to Clopidogrel? (K. Schrör, D) GP2b3a Still Cornerstone of Therapy in ACS!? (G. Montalescot, F) New Antithrombins in Atrial Fibrillation (H. Darius, D) Coffee Break Symposium 4 Metabolic Disease and Other High Risk in ACS Moderators: R. De Caterina (I), J. Slany (A) Aggressive Lipid Lowering and Plaque Regression (K. Huber, A) Treatment of Pre-Diabetics: Helpful or Not? (T. Wascher, A) Renal Dysfunction and Age (H. Darius, D) Diabetes Prevention with RAS-Inhibition (T. Wascher, A) The Mystery of Weight Reduction: Diets, Drugs, or Surgeon? (R. De Caterina, I) 4

5 SCIENTIFIC PROGRAM Tuesday, April 17, Main Lectures III + IV Chair: G. Steg (F) Vasovagal/Neurocardiogenic Syncope Combined CAD / Carotid Interventions (B. Gersh, USA) Meet the Experts III Antiplatelet Agents (F. W. A. Verheugt, NL, H.-J. Rupprecht, D) Coffee Break Poster Discussion III (Antiplatelet Agents in ACS and Coronary Intervention) Moderator: K. Schrör (D) Lunch, Afternoon Break Symposium 5 New Devices for PCI Moderators: R. Zimmermann (CDN), D. Gulba (D) DEB (drug eluting balloon) (U. Zeymer, D) GENOUS-DES (K. Huber, A) ENDEAVOR-DES (H. Darius, D) CoStar-DES, Magnesium Stent (H. Schühlen, D) Yukon-DES (K. Huber, A) Coffee Break Symposium 6 Case Reports: Coronary High Risk Interventions: How to do! Moderators: P. Klinke (CDN), S. King III (USA) Bifurcation Techniques (H. Schühlen, D) Case Presenters: H. Darius (D), G. Gaul (A), D. Gulba (D), H. Schühlen (D), R. Zimmermann (CDN) Management of the No-Reflow Phenomenon (L. Gregorini, I) Social Evening Welcome Reception Music in the Heart the Heart in Music G. Titscher (A) GALA DINER Ladies: long evening dress / ball gown Gentleman: tails 5

6 SCIENTIFIC PROGRAM Wednesday, April 18, Main Lecture V Chair: P. Goldstein (F) Is There Still a Place For Thrombolysis? Is Facilition Useful at All? (A. Ross, USA) Meet the Experts IV STEMI Treatment (O. Pachinger, A, R. Welsh, CDN) Coffee Break Poster Discussion IV (STEMI: Trials and Registries) Moderator: P. Goldstein (F) Lunch, Afternoon Break Symposium 7 Organisation of Networks Moderators: S. Kristensen (DK), U. Zeymer (D) Networks in Europe (P. Goldstein, F) Networks in USA and Canada (R. Welsh, CDN) Update on Networks in Austria (G. Gaul, A) Networks Fail! Reasons and Consequences (B. Gersh, USA) Coffee Break Symposium 8 Controversies in Coronary Interventions Moderators: B. Gersh (USA), K. Huber (A) Too Many Interventions, Not Enough Thoughtful Conservative Care for Non-ACS CAD (F.W.A. Verheugt, NL) Primary PCI: Focus on Culprit Lesion Only? Pro (O. Pachinger, A) Contra (D. Gulba, D) Controversies in Stem Cell Therapy (H. Arnesen, N) 6

SCIENTIFIC PROGRAM Thursday, April 19, 2007 08.00 09.00 Main Lecture VI + VII Chair: H.J. Rupprecht (D) Update in Secondary Prevention (J. Slany, A) Update in PFO/ASD Closure (P. Probst, A)) 09.

7 SCIENTIFIC PROGRAM Thursday, April 19, Main Lecture VI + VII Chair: H.J. Rupprecht (D) Update in Secondary Prevention (J. Slany, A) Update in PFO/ASD Closure (P. Probst, A)) Coffee Break Poster Discussion V (Miscellaneous) Moderator: P. Klinke (CDN) Farewell (H. Darius, D) Departures SPONSORS (per February 2007) ABBOTT VASCULAR (A) HOFFMANN-LA ROCHE (CDN) ALTANA (A) JOHNSON & JOHNSON / CORDIS (A) ASTRAZENECA (A, S) NYCOMED (A, D) BIOMEDICA (A) SANOFI AVENTIS (A) BIOTRONIK (A) SANOFI AVENTIS / BMS (A) BOSTON SCIENTIFIC (A) TRANSLUMINA (A) BRAUN (D) WERFEN AUSTRIA / ORBUS NEICH (A, NL) EUROMED (A) 7

8 FACULTY Harald Arnesen (N) Harald Darius (D) Raffaele De Caterina (I) Georg Gaul (A) Bernard Gersh (USA) Patrick Goldstein (F) Luisa Gregorini (I) Dietrich Gulba (D) Kurt Huber (A) Spencer King III (USA) Peter Klinke (CDN) Steen Kristensen (DK) Gilles Montalescot (F) Otmar Pachinger (A) Peter Probst (A) Allan M. Ross (USA) Hans-Jürgen Rupprecht (D) Karsten Schrör (D) Helmut Schühlen (D) Ulrich Sigwart (CH) Jörg Slany (A) Gabriel Steg (F) Georg Titscher (A) Freek W. A. Verheugt (NL) Thomas Wascher (A) Rob Welsh (CDN) Uwe Zeymer (D) Rodney Zimmermann (CDN)

Coronary Reperfusion. & Secondary Prevention FINAL PROGRAM. Oberlech, Austria April 5 10, 2008 H. DARIUS K. HUBER A. M.

Coronary Reperfusion. & Secondary Prevention FINAL PROGRAM. Oberlech, Austria April 5 10, 2008 H. DARIUS K. HUBER A. M. Coronary Reperfusion & Secondary Prevention DIRECTORS: H. DARIUS K. HUBER A. M. ROSS TOPICS: Acute Coronary Syndromes Antiplatelet Agents Antithrombins Cardiac Resynchronization Chronic Angina Controversies